Related Experiment Videos
Anemia: a problem or an opportunity in radiotherapy?
International Journal of Radiation Oncology, Biology, Physics
|November 1, 1986
Summary
Anemia can negatively impact cancer radiotherapy. Blood transfusions may improve tumor response, but immediate irradiation is crucial to maximize benefits before adaptive mechanisms reduce radiosensitivity.
Area of Science:
- Oncology
- Radiation Oncology
- Cancer Biology
Background:
- Anemia is a common complication in cancer patients undergoing treatment.
- Uncorrected anemia can impair local tumor control during radiotherapy.
- Limited clinical data exist on the overall significance of anemia in radiotherapy.
Purpose of the Study:
- To investigate the impact of anemia on tumor radiosensitivity.
- To evaluate the effect of blood transfusion on tumor response to radiotherapy.
- To explore potential adaptive mechanisms in tumors related to anemia and transfusion.
Main Methods:
- Review of clinical data on anemia in radiotherapy.
- Animal experiments on the influence of acute and chronic anemia on tumor radiosensitivity.
- Studies on the effect of blood transfusion timing on tumor radiosensitivity in anemic animals.
Main Results:
- Anemia can be detrimental to tumor control in radiotherapy.
- Previously anemic patients showed better response to radiotherapy in hyperbaric oxygen.
- Acute anemia caused radioresistance in mouse tumors, but this effect diminished with prolonged anemia.
- Blood transfusion transiently increased tumor radiosensitivity in anemic animals.
Conclusions:
- Anemia management is critical in cancer radiotherapy.
- Blood transfusion can enhance tumor radiosensitivity, but the effect is transient.
- Immediate irradiation post-transfusion is recommended to leverage radiosensitizing effects before adaptive mechanisms intervene.
- Further research is needed to understand the mechanisms of tumor adaptation to anemia and transfusion in human cancer treatment.